No Data
BioLineRx Inks Licensing Deal, Share Purchase Agreement
BioLineRx, Ayrmid Enter License Agreement for Motixafortide Through Gamida Cell
Express News | Biolinerx and Ayrmid Ltd. Enter Into Exclusive License Agreement to Commercialize Aphexda® (Motixafortide) Through Gamida Cell Ltd.
Healthcare Bankruptcies Slow After Peaking in 2023: Report
Express News | Gamida Cell Ltd - Named Joe Wiley as CEO, Rory Nealon as CFO, and Sheila Frame as Chief Commercial Officer
News On Gamida Cell Ltd. (GMDAQ) Now Under GMDA.YY